Results
21,218 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 34 | Konowiecki Joseph SDirector, EVP, Corporate Affairs |  ALHCAlignment Healthcare, Inc.Open-market sale | SELL | $202K 23.5K sh | Sep 18, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 34 | Konowiecki Joseph SDirector, EVP, Corporate Affairs | ALHCAlignment Healthcare, Inc. Open-market sale | SELL | $202K 23.5K sh | Sep 18, 2026 |
| 32 | Allen William TDirector |  SVVSavers Value Village, Inc.Open-market sale | SELL | $241K 26.2K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 31 | Sousa Mauad BrunoDirector |  AUGOAura Minerals Inc.Open-market sale | SELL | $3.04M 33.2K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 31 | Aviv David MelehChief Technology Officer |  RDWRRADWARE LTDOpen-market sale | SELL | $461K 15.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 30 | Cislini JeffSVP & General Counsel |  RVMDRevolution Medicines, Inc.Open-market sale · 10b5-1 plan | SELL | $660K 3,314 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 29 |  Pete SessionsRSelf |  GOOGLAlphabet Inc.Sale | SELL | $15K – $50K | Sep 18, 2026 traded Sep 14, 2026 |
| 29 | Nordstrom Phyllis BEVP, CFO and CAO |  DDD3D SYSTEMS CORPOpen-market sale | SELL | $107K 30.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 29 | Graves Jeffrey ADirector, President and CEO | DDD3D SYSTEMS CORP Open-market sale | SELL | $152K 42.7K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 29 | Saunders Scott JDirector |  NUTXNutex Health Inc.Open-market sale | SELL | $43K 203 sh | Sep 18, 2026 traded Sep 18, 2026 |
| 28 | MacKay Craig CDirector |  EQHEquitable Holdings, Inc.Open-market sale | SELL | $109K 2,000 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 28 | Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER |  WGSGeneDx Holdings Corp.Open-market sale | SELL | $407K 4,141 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 28 | Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $301K 3,039 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 27 | Rosen TamiDirector |  PGYPagaya Technologies Ltd.Open-market sale · 10b5-1 plan | SELL | $173K 8,504 sh | Sep 18, 2026 traded Sep 18, 2026 |
| 26 | Anders JackChief Financial Officer | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $796K 3,992 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 26 | Bartolucci Ryan MChief Accounting Officer |  TEMTempus AI, Inc.Open-market sale · 10b5-1 plan | SELL | $530K 7,062 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 26 | Fortunato DavidDirector, CEO and President |  WLTHWEALTHFRONT CORPOpen-market sale · 10b5-1 plan | SELL | $507K 50.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 26 | von Ahn LuisDirector, President & CEO, Co-Founder, 10% Owner |  DUOLDuolingo, Inc.Open-market sale · 10b5-1 plan | SELL | $4.10M 27.3K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 26 | Imberman AlanCFO and Treasurer | WLTHWEALTHFRONT CORP Open-market sale · 10b5-1 plan | SELL | $773K 76.5K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 26 | Zage George Raymond IIIDirector, 10% Owner |  GRNDGrindr Inc.Open-market sale · 10b5-1 plan | SELL | $5.21M 333.6K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 25 | Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $155K 1,648 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 25 | Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $148K 1,525 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 25 | Roger LisaFormer Chief Financial Officer |  BRFHBARFRESH FOOD GROUP INC.Open-market sale | SELL | $28K 25.3K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 24 | Pete SessionsRSelf |  ABBVAbbVie Inc.Sale | SELL | $15K – $50K | Sep 18, 2026 traded Sep 14, 2026 |
| 24 | Sanfrey Jeffrey ScottChief Operating Officer |  BLBDBlue Bird CorpOpen-market sale | SELL | $250K 4,000 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 24 | Budur KumarCHIEF MEDICAL OFFICER |  HRMYHarmony Biosciences Holdings, Inc.Open-market sale | SELL | $77K 1,800 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 23 | Sandler Alan B.Chief Development Officer | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $67K 336 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Kumar MukulPRESIDENT, ENGINEERING |  PUBMPubMatic, Inc.Open-market sale · 10b5-1 plan | SELL | $134K 8,000 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Fortunato DavidDirector, CEO and President | WLTHWEALTHFRONT CORP Open-market sale · 10b5-1 plan | SELL | $507K 50.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 22 | Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $14K 148 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Wetterwald JulienChief Technology Officer | WLTHWEALTHFRONT CORP Open-market sale · 10b5-1 plan | SELL | $264K 26.1K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 22 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $52K 541 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Mancini AnthonySee Remarks | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $348K 1,747 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $107K 1,079 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $55K 586 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $144K 1,470 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 21 | Budur KumarCHIEF MEDICAL OFFICER | HRMYHarmony Biosciences Holdings, Inc. Open-market sale | SELL | $34K 800 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 20 | Cislini JeffSVP & General Counsel | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $10K 52 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Anders JackChief Financial Officer | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $12K 61 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | von Ahn LuisDirector, President & CEO, Co-Founder, 10% Owner | DUOLDuolingo, Inc. Open-market sale · 10b5-1 plan | SELL | $155K 1,020 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Sandler Alan B.Chief Development Officer | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $975 5 sh | Sep 18, 2026 traded Sep 16, 2026 |